2nd Quarter - Report
PARRY, ROMANI, DECONCINI & SYMMS for POZEN, INC.
Client
Income
$36,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Pharmacy PHA
Support H.R. 2985 - The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| ROMANO ROMANI | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.